New Medicaid Drug Use and Cost Data Highlight Issues for States After Medicare Part D

James Verdier, Ann Bagchi and Dominick Esposito

Mathematica Policy Research Reports from Mathematica Policy Research

Abstract: This issue brief highlights a number of Medicaid prescription drug issues that remain for states after the movement of dual eligibles into the Medicare Part D drug benefit.

Keywords: Medicaid Drug Use; Cost Data; Medicare Part D (search for similar items in EconPapers)
Pages: 4
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mathematica.org/-/media/publications/pdfs/medicaiddruguse.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 404 Not Found (https://www.mathematica.org/-/media/publications/pdfs/medicaiddruguse.pdf [302 Found]--> https://www.mathematica.org/System/404-page-not-found?ItemNotFound=true)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mpr:mprres:3b50f944d17d4e31b17af5be4e45e66e

Access Statistics for this paper

More papers in Mathematica Policy Research Reports from Mathematica Policy Research Mathematica Policy Research P.O. Box 2393 Princeton, NJ 08543-2393 Attn: Communications. Contact information at EDIRC.
Bibliographic data for series maintained by Joanne Pfleiderer () and Cindy George ( this e-mail address is bad, please contact ).